XORTX Therapeutics (XRTX) Goodwill & Intangibles (2020 - 2026)

XORTX Therapeutics (XRTX) has 7 years of Goodwill & Intangibles data on file, last reported at $185695.0 in Q1 2026.

• Quarterly Goodwill & Intangibles rose 3.18% year-over-year to $185695.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185695.0 (up 3.18% YoY) and the FY2025 annual result came in at $185367.0, up 1.23% from the prior year.
• Goodwill & Intangibles was little changed at $185695.0 in Q1 2026, from $185367.0 in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $202878.3 in Q2 2022 to a low of $165991.0 in Q1 2024.
• A 5-year average of $187025.3 and a median of $185699.0 in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles fell 14.08% — and 2025, when it gained 15.45%.
• Tracing XRTX's Goodwill & Intangibles over 5 years: stood at $199401.9 in 2022, then dropped by 13.98% to $171521.0 in 2023, then gained by 6.76% to $183108.0 in 2024, then grew by 1.23% to $185367.0 in 2025, then rose by 0.18% to $185695.0 in 2026.
• The last three Goodwill & Intangibles figures came in at $185695.0 (Q1 2026), $185367.0 (Q4 2025), and $193997.0 (Q3 2025), per Business Quant data.